We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+28.05%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$10.3B
AUM Growth
+$5.25B
Cap. Flow
+$4.62B
Cap. Flow %
45%
Top 10 Hldgs %
41.75%
Holding
2,600
New
918
Increased
493
Reduced
472
Closed
701

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$353M
2
MSFT icon
Microsoft
MSFT
+$352M
3
AAPL icon
Apple
AAPL
+$256M
4
BABA icon
Alibaba
BABA
+$189M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$125M

Sector Composition

Rank Sector Weight
1 Technology 14.28%
2 Consumer Discretionary 10.77%
3 Healthcare 5.09%
4 Industrials 4.03%
5 Financials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCL icon
776
AbCellera Biologics
ABCL
$3.67B
$1.16M 0.01%
+28,850
New +$1.32M
DNB
777
DELISTED
Dun & Bradstreet
DNB
$1.16M 0.01%
+46,507
New +$1.24M
HA
778
DELISTED
Hawaiian Holdings, Inc.
HA
$1.16M 0.01%
+65,440
New +$1.11M
XXII
779
22nd Century Group
XXII
$2.68M
0
DAR icon
780
Darling Ingredients
DAR
$10.4B
$1.15M 0.01%
19,951
-28,240
-59% -$1.35M
FL
781
DELISTED
Foot Locker
FL
$1.15M 0.01%
28,451
-25,943
-48% -$1.01M
MLKN icon
782
MillerKnoll
MLKN
$1.57B
$1.15M 0.01%
33,994
+9,076
+36% +$316K
TEN
783
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$1.15M 0.01%
108,393
+72,528
+202% +$686K
BXC icon
784
BlueLinx
BXC
$665M
$1.15M 0.01%
+39,232
New +$1M
CRUS icon
785
Cirrus Logic
CRUS
$5.78B
$1.15M 0.01%
+13,961
New +$1.05M
IPHI
786
DELISTED
INPHI CORPORATION
IPHI
$1.15M 0.01%
+7,133
New +$1M
Z icon
787
Zillow
Z
$8.07B
$1.14M 0.01%
8,804
+8,315
+1,700% +$920K
MCRB icon
788
Seres Therapeutics
MCRB
$45.8M
$1.14M 0.01%
+2,331
New +$1.37M
FMAC.U
789
DELISTED
FirstMark Horizon Acquisition Corp. Units, each consisting of one share of Class A common stock and
FMAC.U
$1.14M 0.01%
+100,000
New +$1.05M
CURI icon
790
CuriosityStream
CURI
$164M
$1.14M 0.01%
+81,577
New +$830K
ALPN
791
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.14M 0.01%
+90,229
New +$886K
SIL icon
792
Global X Silver Miners ETF NEW
SIL
$5.4B
$1.13M 0.01%
+24,724
New +$1.08M
AACQU
793
DELISTED
Artius Acquisition Inc. Unit
AACQU
$1.12M 0.01%
100,000
CARR icon
794
Carrier Global
CARR
$49.8B
$1.12M 0.01%
29,770
+16,640
+127% +$602K
BPOP icon
795
Popular Inc
BPOP
$10.8B
$1.12M 0.01%
19,877
-18,561
-48% -$881K
PAYC icon
796
Paycom
PAYC
$10.3B
$1.12M 0.01%
+2,474
New +$986K
ZEV
797
DELISTED
Lightning eMotors, Inc.
ZEV
$1.11M 0.01%
+4,220
New +$933K
TECH icon
798
Bio-Techne
TECH
$11.3B
$1.11M 0.01%
13,996
+6,624
+90% +$480K
SAM icon
799
Boston Beer
SAM
$1.91B
$1.11M 0.01%
1,112
-9,511
-90% -$9.13M
AIG icon
800
American International
AIG
$39.8B
$1.1M 0.01%
+29,114
New +$1.03M

Similar funds

Michael Gelband's Q4 2020 Portfolio in Review

As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.

  • Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
  • Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
  • Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
  • Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
  • Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
  • Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
  • Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.